| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/01/2007 | WO2007013421A1 Novel nitrogenated heterocyclic compound |
| 02/01/2007 | WO2007013078A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 02/01/2007 | WO2007012254A1 Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027187 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | CA2616150A1 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1748031A1 Method for producing spherical activated carbon |
| 01/31/2007 | EP1747781A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients |
| 01/31/2007 | EP1747780A1 Drug for prevention or treatment of diabetes |
| 01/31/2007 | EP1746998A1 Combination therapy for lower urinary tract symptoms |
| 01/31/2007 | EP1746885A1 Agonists of a2a adenosine receptors for treatment of diabetic nephropathy |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1903356A Oral liquor for treating prostate diseases |
| 01/31/2007 | CN1903355A Oral liquor for treating prostate diseases |
| 01/31/2007 | CN1903345A Traditional Chinese medicine pills for tonifying kidney and strengthening bones for treating osteoarthritis and prodn. method thereof |
| 01/31/2007 | CN1903338A Oral liquor for treating prostate disease |
| 01/31/2007 | CN1903332A Traditional Chinese medicine prepn. for treating calculosis |
| 01/31/2007 | CN1903301A Traditional Chinese medicine oral liquor for treating prostate diseases |
| 01/31/2007 | CN1903292A Oral liquor for treating prostate diseases |
| 01/31/2007 | CN1903288A Traditional Chinese medicated decoction for treating prostatitis |
| 01/31/2007 | CN1903281A Traditional Chinese medicine composition for treating urinary system infection |
| 01/31/2007 | CN1903266A Oral liquor for treating prostate diseases |
| 01/31/2007 | CN1903265A Traditional Chinese medicine composition for treating nycturia and its preparing method |
| 01/31/2007 | CN1903202A Compounding medicine for treating nephropathy |
| 01/31/2007 | CN1903189A Medicine composition contg. Tamsulosin and calcium antagonist |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297261C Fatty acyl acetaldehyde transfusion preparation and its preparing method |
| 01/31/2007 | CN1297260C Fatty acyl acetaldehyde powder projection and its preparing method |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2185794C Agent for relieving side effects caused by immunosuppressants |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/25/2007 | WO2007010547A1 A phyto-medicine and a process for the preparation thereof |
| 01/25/2007 | WO2007010504A2 Acid addition salts of isoindoles acting as adrenergic receptor antagonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009607A1 Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2007009354A1 Pyrrolidine derivative intermediates,preparation and usage thereof |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021487 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021391 Preventive/remedy for urinary disturbance |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020231 Remedy for kidney diseases |
| 01/25/2007 | CA2615426A1 Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 01/25/2007 | CA2614327A1 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1745793A1 Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease |
| 01/24/2007 | EP1745792A1 Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease |
| 01/24/2007 | EP1744773A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus |
| 01/24/2007 | EP1744746A2 Use of melatonin in preventing postoperative complications |
| 01/24/2007 | EP1638547B1 Composition for preventing urinary system infections |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902166A Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |